Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 11, 2010 - Issue 7
Submit an article Journal homepage
2,432
Views
23
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study

Istvan Bitter Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary
,
Tamás Treuer Neuroscience Research, Eli Lilly & Company, Budapest, HungaryCorrespondence[email protected]
,
Nesrin Dilbaz Ankara Numune Research and Training Hospital, Ankara, Turkey
,
Igor Oyffe Lev-Hasharon Mental Health Center, Natania, Israel
,
Eda M. Ciorabai Spitalul Judetean Constanta, Romania
,
Severiano L. Gonzalez Dr. Martinez Col Doctores, Monterrey, Nuevo Leon, Mexico
,
Sandra Ruschel Hospital Mario Kröeff-Serviço de Psiquiatria, Rio de Janeiro, Brazil
,
Jolanta Salburg Area Medical Center Vienna, Neuroscience Research, Eli Lilly & Company, Vienna, Austria
&
Yulia Dyachkova Area Medical Center Vienna, Neuroscience Research, Eli Lilly & Company, Vienna, Austria
 show all
Pages 894-903 | Received 18 Mar 2010, Accepted 23 Jun 2010, Published online: 26 Jul 2010

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Hesham M. Tawfeek, Waleed Faisal & Ghareb M. Soliman. (2018) Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats. Pharmaceutical Development and Technology 23:5, pages 496-503.
Read now
Diego Novick, William Montgomery, Tamas Treuer, Ai Koyanagi, Jaume Aguado, Susanne Kraemer & Josep Maria Haro. (2017) Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder. Patient Preference and Adherence 11, pages 1019-1025.
Read now
Hemlata G. Patil, Roshan V. Tiwari, Michael A. Repka & Kamalinder K. Singh. (2016) Formulation and development of orodispersible sustained release tablet of domperidone. Drug Development and Industrial Pharmacy 42:6, pages 906-915.
Read now
William Montgomery, Tamas Treuer, Jamie Karagianis, Haya Ascher-Svanum & Gavan Harrison. (2012) Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. Patient Preference and Adherence 6, pages 109-125.
Read now

Articles from other publishers (19)

Hiba Mutwalli, Johanna Louise Keeler, Sevgi Bektas, Namrata Dhopatkar, Janet Treasure & Hubertus Himmerich. (2023) Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis. Journal of Psychiatric Research 160, pages 137-162.
Crossref
Jonáš Boček. (2022) Efficacy/safety of olanzapine orodispersible tablets. Psychiatrie pro praxi 23:3, pages 187-190.
Crossref
Maria Carvalho & Isabel Almeida. (2022) The Role of Pharmaceutical Compounding in Promoting Medication Adherence. Pharmaceuticals 15:9, pages 1091.
Crossref
Hardik Gandhi. (2022) Physician Preferences for Olanzapine Standard Oral Tablets and Orally Disintegrating Tablets: A Cross-Sectional Survey. Journal of Pharmacology and Pharmacotherapeutics 13:1, pages 97-98.
Crossref
Péter Takács, Péter Kunovszki, Valeria Timtschenko, László Fehér, Tamás Balázs, Ramóna Hegyi, Pál Czobor & István Bitter. (2022) Comparative Effectiveness of Second Generation Long-acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary: An Update. Schizophrenia Bulletin Open 3:1.
Crossref
Rédai Emőke, Péter Csilla, Kovács Béla, Ciurba Adriana, Todoran Nicoleta, Antonoaeae Paula, Vlad Robert-Alexandru & Sipos Emese. (2020) Formulation and study of nebivolol containing orodispersable tablets. Bulletin of Medical Sciences 93:1, pages 27-32.
Crossref
Enrica Menditto, Valentina Orlando, Giuseppe De Rosa, Paola Minghetti, Umberto Musazzi, Caitriona Cahir, Marta Kurczewska-Michalak, Przemysław Kardas, Elísio Costa, José Sousa Lobo & Isabel Almeida. (2020) Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence. Pharmaceutics 12:1, pages 44.
Crossref
P. Takács, P. Czobor, L. Fehér, J. Gimesi-Országh, P. Fadgyas-Freyler, M. Bacskai, P. Rakonczai, A. Borsi, R. Hegyi, T. Németh, J. Sermon & I. Bitter. (2019) Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary. PLOS ONE 14:6, pages e0218071.
Crossref
Andrew J. Cutler & Gregory W. Mattingly. (2017) Beyond the pill: new medication delivery options for ADHD. CNS Spectrums 22:6, pages 463-474.
Crossref
Nélio Drumond, Diana A. van Riet-Nales, Fatma Karapinar-Çarkit & Sven Stegemann. (2017) Patients’ appropriateness, acceptability, usability and preferences for pharmaceutical preparations: Results from a literature review on clinical evidence. International Journal of Pharmaceutics 521:1-2, pages 294-305.
Crossref
Jun Soo Kwon, Sung Nyun Kim, Jaewook Han, Sang Ick Lee, Jae Seung Chang, Jung-Seok Choi, Heon-Jeong Lee, Seong Jin Cho, Tae-Youn Jun, Seung-Hwan Lee, Changsu Han, Kyoung-Uk Lee, Kyung Kyu Lee & EunJung Lee. (2015) Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics. International Clinical Psychopharmacology 30:6, pages 320-328.
Crossref
Marta Slavkova & Jörg Breitkreutz. (2015) Orodispersible drug formulations for children and elderly. European Journal of Pharmaceutical Sciences 75, pages 2-9.
Crossref
Maarten Bak, Annemarie Fransen, Jouke Janssen, Jim van Os & Marjan Drukker. (2014) Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis. PLoS ONE 9:4, pages e94112.
Crossref
Emilio Sacchetti, Antonio Vita, Alberto Siracusano & Wolfgang FleischhackerEmilio Sacchetti & Antonio Vita. 2014. Adherence to Antipsychotics in Schizophrenia. Adherence to Antipsychotics in Schizophrenia 1 84 .
David Hobbs, Jamie Karagianis, Tamas Treuer & Joel Raskin. (2013) An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report. Drugs in R&D 13:4, pages 281-288.
Crossref
Susanne Kraemer, Florence Chartier, Béatrice Augendre‐Ferrante, Vassiliki Psarra, Yulia D'yachkova, Anke Beselin & Fréderic Rouillon. (2012) Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1‐year European observational study. Human Psychopharmacology: Clinical and Experimental 27:3, pages 284-294.
Crossref
Ichiro Kusumi, Minoru Honda, Keiichi Uemura, Yasuhumi Sugawara, Masako Kohsaka, Akihiko Tochigi & Tsukasa Koyama. (2012) Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 36:2, pages 313-317.
Crossref
Alfonso Carvajal & Luis H. Martín Arias. 2012. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions 51 84 .
Dorrit Østergaard Nilausen, R.G.J.A. Zuiker & Joop van Gerven. (2011) The Perception and Pharmacokinetics of a 20-mg Dose of Escitalopram Orodispersible Tablets in a Relative Bioavailability Study in Healthy Men. Clinical Therapeutics.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.